Amendment: SEC Form SCHEDULE 13D/A filed by Retractable Technologies Inc.
$RVP
Medical/Dental Instruments
Health Care
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 8)
|
Retractable Technologies, Inc. (Name of Issuer) |
Common Stock (Title of Class of Securities) |
76129W105 (CUSIP Number) |
John W. Fort III 511 Lobo Lane, Little Elm, TX, 75068 972-294-1010 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
08/19/2025 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 76129W105 |
| 1 |
Name of reporting person
Thomas J. Shaw | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
 (b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
PF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
16,476,925.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
55.0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock |
| (b) | Name of Issuer:
Retractable Technologies, Inc. |
| (c) | Address of Issuer's Principal Executive Offices:
511 Lobo Lane, Little Elm,
TEXAS
, 75068-0009. |
| Item 4. | Purpose of Transaction |
As reported in other public filings for the Reporting Person and Issuer, the Reporting Person entered into a written plan for the purchase of Retractable Technologies, Inc. common stock intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) on August 22, 2024. In accordance with the plan, trading began November 20, 2025 and may continue through November 19, 2025 if not earlier terminated. | |
| Item 5. | Interest in Securities of the Issuer |
| (a) | 16,476,925 (55.0%) |
| (b) | Sole power to vote 15,976,925 shares and sole power to dispose 16,145,325 shares |
| (c) | All of the following open market common stock purchases were made by Mr. Shaw's broker pursuant to his 10b5-1 Plan and reported on Form 4 in the last 60 days. All prices are expressed as weighted average per share prices: 06/30/25 - 1,347 shares at $0.6221; 07/01/25 - 8,574 shares at $0.628; 07/11/25 - 8,536 shares at $0.653; 07/21/25 - 5,000 shares at $0.66; 07/30/25 - 27,288 shares at $0.7358; 07/31/25 - 5,339 shares at $0.7147; 08/01/25 - 1,575 shares at $0.703; 08/04/25 - 30,881 shares at $0.7157; 08/07/25 - 49,541 shares at $0.74; 08/11/25 - 2,100 shares at $0.8118; 08/12/25 - 8,411 shares at $0.823; 08/13/25 - 3,983 shares at $0.8015; 08/14/25 - 3,103 shares at $0.7875; 8/15/25 - 10,980 shares at $0.7948; 08/18/25 - 32,935 shares at $0.795; 08/19/25 - 9,042 shares at $0.7963. |
| (d) | The beneficiaries of two trusts have the right to receive dividends from, or the proceeds from the sale of, the following number of shares of common stock beneficially owned by Mr. Shaw: (i) 331,600 shares; and (ii) 500,000 shares. |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|